TINA WITHROW: Open Payments
NPI 1063928521 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,914 in 122 payments from 37 companies in 2025. Trend: 2023 $3,634 · 2024 $3,534 · 2025 $2,914
Food & beverage: $2,840Education: $75
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $219 |
| E.R. Squibb & Sons, L.L.C. | 10 | $199 |
| Novartis Pharmaceuticals Corporation | 7 | $170 |
| Merck Sharp & Dohme LLC | 6 | $163 |
| Celgene Corporation | 8 | $156 |
| Janssen Biotech, Inc. | 6 | $143 |
| Daiichi Sankyo Inc. | 6 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $127 |
| Novocure Inc. | 1 | $119 |
| JAZZ PHARMACEUTICALS INC. | 5 | $119 |
Products named: OPDIVO, KEYTRUDA, ENHERTU, REBLOZYL, Nubeqa, Optune Lua (NovoTTF-200T), ZEPZELCA, LONSURF.
Industry payments across SC — which companies pay providers there.
